MDT - Tandem Diabetes hits 52-week after guidance cut
2023-11-02 13:28:08 ET
More on Tandem
- Tandem Diabetes Care, Inc. (TNDM) Q3 2023 Earnings Call Transcript
- Tandem Diabetes: Cash Flow And Profitability Trends A Drag On Equity Performance, Reiterate Hold
- Tandem Diabetes Care GAAP EPS of -$0.51 in-line, revenue of $185.6M misses by $7.24M
- Tandem Diabetes Care Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Tandem Diabetes Care
For further details see:
Tandem Diabetes hits 52-week after guidance cut